Compare Erasca Inc. Common Stock (ERAS) vs UDR Inc. Common Stock (UDR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Erasca Inc. Common Stock vs UDR Inc. Common Stock — how do they compare? Erasca Inc. Common Stock trades at $14.6 (market cap $5.17B), while UDR Inc. Common Stock trades at $33.9 (market cap $10.93B). The key difference: UDR Inc. Common Stock is far larger — about 2.1× Erasca Inc. Common Stock's market cap, and UDR Inc. Common Stock pays a 5.12% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 1 Days and UDR Inc. Common Stock for 0 Days on average.
| ERAS | UDR | |
|---|---|---|
Market Cap | $5.17B | $10.93B |
Volume | 5,313,379 | 2,607,837 |
Sector | Health | Real Estate |
52-Week High | $22.47 | $41.24 |
52-Week Low | $2.20 | $33.27 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $4.95B | $16.96B |
Dividend Yield | — | 5.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ERAS trades at $14.78, down 4.4% today, with a bullish technical signal from moving averages and a consensus analyst price target of $22.50. The company is a clinical-stage oncology firm with no revenue, reporting a net loss of $124.55 million in 2025, but holds significant liquidity and has three potential registration-enabling trials ahead. Recent news highlights FDA Fast Track designation for its lead candidate ERAS-0015.
The outlook is speculative, driven by clinical trial progress; upside exists if trials succeed, but high cash burn and shareholder investigations pose substantial risks. Investment hinges on binary outcomes from drug development, making it suitable only for risk-tolerant investors focused on biotech.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Erasca Inc. Common Stock
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →About UDR Inc. Common Stock
UDR, Inc. is a self-administered real estate investment trust that owns, operates, develops, and redevelops multifamily apartment communities across targeted US markets. The company generates income primarily through leasing apartment homes, with a portfolio concentrated in coastal and Sunbelt metropolitan areas.
Read more on UDR →
